Find Academic Supervisors

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +5 more

Professor Jennifer Whitty is an applied health economist at the University of East Anglia , affiliated with the Norwich Medical School and the Centre of Research Excellence in Telehealth . Her research bridges health economics, patient preferences, and health policy, with a focus on quality of life valuation and economic evaluation. Education: Doctor of Philosophy (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992) Her work emphasizes person-centered methodologies , particularly discrete choice experiments, to evaluate patient and public preferences for healthcare delivery and outcomes. Key research areas include: Treatment burden and quality of life in chronic diseases like cystic fibrosis Economic evaluation of pharmaceuticals and health technologies Asset-based approaches to community health Priority-setting frameworks in health policy Prof. Whitty has secured over AU$27 million in research funding from organizations including the NHMRC and National Institute for Health and Care Research , and serves on editorial boards for Medical Decision Making and Applied Health Economics and Health Policy .

• Health Economics
• Preferences for Health and Health Care
• Valuing Health Outcomes
• +7 more

Professor Shaun Larkin is a part-time academic at the School of Public Health , University of Sydney, specializing in Health Policy and Financing . He is affiliated with the Leeder Centre for Health Policy, Economics and Data and a member of the Charles Perkins Centre . With a career spanning executive roles at HCF and non-executive directorships in health startups, his work bridges academia and industry. Education : Harvard Business School alumnus with a HlthScD, MBA, MHSc, and BHA. His research focuses on health economics , health policy , and health services management , emphasizing: Translational research in healthcare financing Trends in private-public healthcare partnerships Price transparency in private health insurance Leadership in health systems Chronic disease management Quality use of medicines His publications reveal a trajectory from foundational work in: Psychiatric services data standardization (2000) Heart disease and diabetes management (2013-2015) Telehealth interventions (2017-2018) Private sector policy frameworks (2019-2020) Saudi Arabian health reforms (2022-present) Private equity in healthcare (2025) As an advisor, he currently supervises research students on topics including: Quality use of medicines in Saudi Arabia Sustainable financial models for private hospitals Patient-reported outcome measures in Australia He also contributes to the Leeder Centre and engages with global health startups as an investor and advisor.

• Health economics
• Health policy
• Health services and management
• +2 more

Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .

• Mental Health
• Behavioral Science
• Trauma
• +6 more

Michael James Herdman is an Honorary Visiting Associate Professor at the National University of Singapore’s Saw Swee Hock School of Public Health. He serves as Head of Health Outcomes Research at the Office of Health Economics in London and Director of Insight Consulting & Research in Barcelona. His work focuses on patient-reported outcome (PRO) measures, including their development, validation, and application in healthcare evaluation. He has been a key member of the EuroQol Group for 25 years, contributing to initiatives like the EQ-5D-5L tool and pediatric health measurement standards. Education: MSc in Bioethics and Law from the University of Barcelona (1996–1998) and BSc Philosophy (Honors) from the University of Hull (1981–1985). Research Interests: Central to Herdman’s work are PRO measures, health technology assessment, and outcomes research, particularly in younger populations and pediatric health. He has authored over 150 peer-reviewed articles and book chapters, with notable contributions to cross-cultural adaptation of health instruments and systematic reviews on pediatric vaccines. Professional Activities: Provides consulting services to pharmaceutical companies and public health organizations. His work bridges academic research and practical applications in health economics and policy. Labs/Teams: Active in the EuroQol Group’s Executive Committee and Younger Populations Working Group, and leads Insight Consulting & Research.

• Patient Reported Outcomes
• Health Technology Assessment
• Outcomes Research
• +3 more

Dr. Timothy Hresko is a Professor of Orthopedic Surgery at Harvard Medical School and serves as an Orthopedic Surgeon in the Orthopedics and Sports Medicine Department at Boston Children's Hospital. He also holds the position of Director of Spine Research and Quality Improvement in the Department of Orthopedic Surgery. Dr. Hresko received his medical degree from Columbia University, College of Physicians and Surgeons in 1981. He completed his internship at New England Deaconess Hospital in 1982, followed by residency at New England Medical Center in 1987, and a fellowship at Boston Children's Hospital in 1988. He is certified by the American Board of Orthopedic Surgery. His research focuses on orthopedic surgery, particularly spine surgery and pediatric orthopedics. Dr. Hresko's work centers on scoliosis treatment, spinal deformity correction, and outcomes of pediatric spinal fusion surgeries. He has conducted extensive research on surface topography measurements for scoliosis assessment, bracing techniques for adolescent idiopathic scoliosis, and surgical outcomes for various spinal conditions. His recent work explores the biomechanical effects of thoracolumbosacral orthosis design and the relationship between spinal deformity and patient self-image. Dr. Hresko's recent publications demonstrate a strong emphasis on technological advancements in spine surgery, including robotic pedicle screw placement and computer vision algorithms. His work also explores the relationship between socioeconomic factors and surgical outcomes, as well as innovative approaches to non-surgical management of scoliosis. Scoliosis Research Society (SRS) Pediatric Orthopaedic Society of North America (POSNA) American Academy of Orthopaedic Surgeons (AAOS) American Board of Orthopaedic Surgery As Director of Spine Research and Quality Improvement, Dr. Hresko leads initiatives to enhance patient outcomes and optimize care pathways for children with spinal conditions. His work emphasizes evidence-based approaches to pediatric spine care, with particular attention to quality improvement and research translation into clinical practice.

• Orthopedic Surgery
• Spine Surgery
• Pediatric Orthopedics
• +3 more

James Fogarty is a Professor at the Paul G. Allen School of Computer Science & Engineering, University of Washington. He serves as a core member of the DUB Group (Design. Use. Build.), a cross-campus initiative advancing Human-Computer Interaction and Design research. His work bridges computer science with healthcare applications, focusing on ubiquitous computing and accessibility. Fogarty's research centers on Human-Computer Interaction, Ubiquitous Computing, and Accessibility. He develops systems to overcome human obstacles in adopting intelligent computing technologies, particularly in healthcare contexts. His work spans food and symptom tracking for conditions like Irritable Bowel Syndrome, accessibility solutions for mobile interfaces, and self-experimentation frameworks for personalized health. Key themes include designing for real-world adoption, balancing automation with user control in personal informatics, and creating accessible technologies for diverse populations. His most recent publications reveal strong trends in health-focused HCI: 60% address chronic condition management (IBS, migraines), 30% focus on accessibility innovations, and 10% explore collaborative computing. Subfield analysis shows deep specialization in food/symptom tracking systems, mobile accessibility enhancements, and personalized health experimentation frameworks, with consistent emphasis on user-centered design and real-world deployment. Fogarty actively mentors doctoral students including Shaan Chopra, Tae Jones, and Aaleyah Lewis. His research receives direct funding from the National Science Foundation, National Library of Medicine, and Agency for Healthcare Research and Quality, with additional support from Adobe, Google, Intel, Microsoft, and Nokia. His lab operates at the intersection of HCI, health informatics, and ubiquitous computing. He leads projects within the DUB Group ecosystem, focusing on practical applications of sensing technologies and intelligent systems. Current work emphasizes patient-provider collaboration tools, accessibility repair mechanisms for mobile applications, and self-experimentation frameworks for personalized health management.

• Human-Computer Interaction
• Ubiquitous Computing
• Accessibility
• +3 more

Nick Bansback is an Honorary Visiting Professor in the School of Population and Public Health at the University of British Columbia (primary affiliation) and affiliated with NUS Saw Swee Hock School of Public Health. His research focuses on maximizing healthcare value through economic evaluation, patient preference measurement, and decision analysis. He holds a PhD in Health Economics and Decision Sciences (University of Sheffield, 2010), an MSc in Health Economics (2004), and a BSc in Mathematics (2001). Key research areas include health technology assessment, patient-reported outcomes, and cost-effectiveness analysis of treatments for chronic conditions like rheumatoid arthritis and multiple sclerosis. He has pioneered methods for incorporating patient preferences into healthcare decisions, including developing decision aids and discrete-choice experiments. His work has been recognized with awards such as the UBC Killam Research Award (2020) and the Canadian Agency for Drugs and Technology in Health Rising Star Award (2016). He has contributed to over 30 peer-reviewed publications, emphasizing practical applications of health economics to improve healthcare resource allocation and patient-centered care. Prof. Bansback’s career spans postdoctoral research at UBC, health economics roles at the Centre for Health Evaluation and Outcomes Sciences, and early research at the University of Sheffield. His interdisciplinary approach bridges clinical practice, policy, and quantitative methods to address complex healthcare challenges.

• Health Economics
• Decision Analysis
• Health Technology Assessment
• +5 more

Prof. Dr. Jonas Schreyögg is a Professor of Healthcare Management and Scientific Director of the Hamburg Center for Health Economics (HCHE) at the University of Hamburg since 2010. He holds the Chair of Healthcare Management and serves as Deputy Chairman of the German Council of Economic Experts for Health and Nursing Care. His roles also include memberships on scientific advisory boards and associated research at Stanford University. Education & Career: Doctorate and Habilitation (2008) from Technical University of Berlin Former Professor at Ludwig-Maximilians-University of Munich (LMU Munich) Junior Professor at Technical University of Berlin Harkness Fellow at Stanford University (2006–2007) Research Interests: Focus on healthcare systems, health economics, hospital payment reforms, pandemic policy responses, and healthcare workforce optimization. Key areas include DRG systems, healthcare competition, and socioeconomic disparities in health outcomes. He has conducted extensive research on the impact of policy interventions during the COVID-19 pandemic, including lockdown perceptions and vaccine acceptance. Grants & Awards: Recipient of the Harkness Fellowship, German National Academic Foundation doctoral scholarship, and multiple research grants. His work has been published in leading journals like Health Affairs , Journal of Public Health , and Social Science & Medicine . Professional Activities: Engaged in international collaborations and teaching in Norway, Singapore, Taiwan, and the U.S. He advises on healthcare policy and has contributed to high-profile reports on healthcare workforce sustainability and pandemic response strategies.

• Healthcare Management
• Health Economics
• Health Policy
• +5 more

LUO Nan is an Associate Professor and Domain Leader (Health Systems & Behavioral Sciences) at the NUS Saw Swee Hock School of Public Health (Primary affiliation) and holds a joint appointment at the NUS Yong Loo Lin School of Medicine. Their research focuses on health-related quality of life measurement, health services research, and health economics. Education: B.Sc. (1996) Shenyang Pharmaceutical University, China; M.Sc. (1999) Shenyang Pharmaceutical University, China; Ph.D. (2004) National University of Singapore. Research interests include advancing methodologies for health outcomes measurement, evaluating healthcare systems' effectiveness, and informing policy through economic analyses. Their work bridges clinical practice, public health, and health economics, with notable contributions to pharmacoeconomics and health services research. Major publications span quality of life assessment frameworks and economic evaluations in healthcare. Professional activities include roles as a Health Economics Specialist at the Singapore Ministry of Health and adjunct positions at Singapore Eye Research Institute. Administrative leadership includes guiding the Health Systems and Behavioral Sciences domain. Luo has held grants and consulting roles, though specific funding details are not listed here. Their work is associated with collaborative initiatives like the Health Intervention and Policy Evaluation Research (HIPER) cohort studies.

• Health-related quality of life measurement
• Health services research
• Public Health
• +3 more

Rachel M. Werner, MD, PhD, is a Professor of Medicine at the Perelman School of Medicine and holds the Robert D. Eilers Memorial – William Maul Measey Professorship in Health Care Management and Economics at the Wharton School , both at the University of Pennsylvania . She serves as Executive Director of the Leonard Davis Institute of Health Economics and is an Attending Physician at the Philadelphia Veterans Affairs Medical Center . Dr. Werner is a Core Investigator with the VA Center for Health Equity Research and Promotion and a Senior Fellow at the Leonard Davis Institute . Education: B.A. in Political Science, Macalester College (1992) M.D. in Medicine, University of Pennsylvania School of Medicine (1998) Ph.D. in Health Economics, Wharton School, University of Pennsylvania (2004) Dr. Werner's research program, spanning over two decades, explores the effects of health care payment policies and quality improvement incentives on delivery systems, with a focus on unintended consequences such as worsening racial disparities through public quality reporting. She employs causal inference methods from observational data and leads R01 grants from the Agency for Healthcare Research and Quality (AHRQ) and the National Institute on Aging (NIA) . Scientific Awards: Alice Hersh New Investigator Award Presidential Early Career Award for Scientists and Engineers American Federation of Medical Research (AFMR) Outstanding Investigator Award Elected member of the National Academy of Medicine Her work influences federal and state advisory committees and evaluates Medicaid policies , Medicare systems, and post-acute care models . She directs a VA national center assessing the medical home effectiveness and collaborates with institutions like the Center for Health Equity Research and Promotion and the Center for Health Incentives and Behavioral Economics .

• Health Economics
• Health Care Disparities
• Quality Improvement Incentives
• +5 more

Jeffrey T. Jensen, M.D., M.P.H., is the Leon Speroff Professor and Vice Chair for Research in the Department of Obstetrics and Gynecology at Oregon Health & Science University (OHSU). He holds joint appointments as Professor of Public Health and Preventive Medicine and serves as a Core Scientist at the Oregon National Primate Research Center (ONPRC). Dr. Jensen completed his medical degree at Emory University, a Master of Public Health at the University of Washington, and residency training at OHSU. Research Focus: Dr. Jensen leads translational and clinical research programs focused on contraceptive innovation. His work emphasizes nonhuman primate models to develop: Novel contraceptive agents targeting oocyte-specific pathways Non-surgical permanent contraception methods Optimized emergency contraception for diverse populations He directs OHSU's Women’s Health Research Unit and the Gates Foundation-funded Oregon Permanent Contraception Research Center (OPERM). Recent Publications: His 15 most recent articles (2023-2025) demonstrate concentrated expertise in: Advanced hormonal contraceptive formulations (IUDs, vaginal rings, oral agents) Weight-adjusted dosing strategies for emergency contraception Biomarker validation for contraceptive efficacy monitoring Real-world assessment of bleeding pattern management Leadership & Collaboration: Dr. Jensen is Principal Investigator of the NICHD Contraception Clinical Trials Network and collaborates with global health organizations (CONRAD, FHI360, Population Council). He serves as Deputy Editor for the journal Contraception and consults for multiple pharmaceutical companies on product development.

• Contraception
• Reproductive Health
• Translational Research
• +2 more

Marita Dale is a Senior Lecturer in the Discipline of Physiotherapy at the University of Sydney and an Early Career Researcher affiliated with the Charles Perkins Centre. She specializes in cardiorespiratory physiotherapy, focusing on exercise interventions for chronic respiratory and cardiac diseases, particularly asbestos-related and dust-related conditions. Her work emphasizes improving accessibility to pulmonary rehabilitation services and leveraging mHealth technologies for patient care. Education: PhD in Physiotherapy (2016, University of Sydney). Her research interests include optimizing pulmonary rehabilitation through mobile health platforms, such as the m-PR™ app, and investigating pediatric burn injury rehabilitation, including orthosis use and scar prevention. She also explores multimorbidity management and simulation-based learning in healthcare education. Recent studies have highlighted her contributions to COPD care protocols, telehealth implementation during the pandemic, and qualitative analyses of patient experiences. Major awards: Sydney School of Health Sciences Teaching Citation (2022), Ashurst Prize for Outstanding Oral Presentation (2015), Helga Pettitt FHS Postgraduate Study Award (2010). Marita supervises Honours, Masters, and PhD students, including Mitchell Taylor on airway clearance in bronchiectasis. Her teaching spans undergraduate and postgraduate programs in cardiopulmonary and musculoskeletal physiotherapy. She collaborates on projects like the Lung Support Service, a nationwide text message program for chronic respiratory patients during the pandemic, and contributed to the commercialization of the Perx-R app for pulmonary rehab. Labs/teams: Active member of the Charles Perkins Centre, focusing on interdisciplinary chronic disease research and healthcare innovation.

• Pulmonary Rehabilitation
• Chronic Respiratory Diseases
• Exercise Physiology
• +4 more

Jeff Searl is a Professor in the Department of Communicative Sciences and Disorders at Michigan State University (MSU), within the College of Communication Arts and Sciences. Previously, he held faculty roles at the University of Kansas Medical Center’s Hearing and Speech Department and the Otolaryngology – Head & Neck Surgery Department. He earned his Ph.D. from the University of Kansas. His research focuses on understanding how chemoradiation and surgery for head and neck cancers affect speech and voice production. The goal is to develop clinical practices that preserve or rehabilitate communication for patients post-treatment. His methods include physiological, acoustic, and auditory-perceptual measurements. Key emphases include optimizing communication while balancing speech intelligibility, physical/cognitive effort, and associated fatigue. Recent work addresses pandemic impacts on laryngectomy patients, clinician practices during crises, and vocal effort measurement across cultures. His lab investigates articulatory pressures, tracheoesophageal speech dynamics, and dysphagia treatment innovations. Though no specific awards are listed, his contributions to voice rehabilitation and clinical methodologies are significant. Dr. Searl advises on telemedicine applications for Parkinson’s voice therapy, group therapy feasibility, and alaryngeal communication modalities. His lab at MSU collaborates on interdisciplinary projects involving speech-language pathologists, engineers, and oncologists to advance communication restoration technologies.

• Speech Production
• Head and Neck Cancer Rehabilitation
• Voice Assessment
• +3 more

Christopher G. Tarolli, MD is an Associate Professor in the Department of Neurology at the University of Rochester School of Medicine and Dentistry. He specializes in movement disorders, particularly Parkinson's disease and Huntington's disease, and serves as Director of the Mind, Brain, Behavior neuroscience course and Associate Program Director of the Adult Neurology Residency Program. His work bridges clinical practice with research in wearable sensor technology, palliative care, and health professions education. MD from SUNY Downstate College of Medicine (2012) Residency & Fellowship at University of Rochester Medical Center (2012-2018) Masters of Science in Health Professions Education (Warner School, UR) Dr. Tarolli's research focuses on novel technologies for neurological assessment, practice-based research in movement disorders, and palliative care models. He has contributed to studies on wearable sensors, remote video-based clinical trials, and symptom burden analysis in Parkinson's and Huntington disease. His work emphasizes patient-centered care and digital health innovation. Recent publications highlight his expertise in: Wearable sensor validation for neurodegenerative diseases Telemedicine applications in Parkinson's disease Palliative care integration across disease trajectories Smartphone-based Huntington's disease monitoring Machine learning for movement disorder severity quantification Quality measures in Parkinson's care Awards include the Herbert W. Mapstone Prize for Excellence in Second Year Teaching and participation in the American Academy of Neurology Emerging Leaders Program. Dr. Tarolli also leads clinical research initiatives and educational programs at the University of Rochester Medical Center.

• Movement Disorders
• Parkinson's Disease
• Huntington's Disease
• +4 more